Relief Therapeutics Holding AG
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need. The company focuses on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications is being investigated in two U.S. Phase 2b/3 clinical trials in acute respiratory deficiency due to COVID-19, as well as in Phase 2 clinical trial for the treatment of pulmonary sarcoidosis. The company is also involved in clinical development of RLF-100 for other indications in acute and chronic lung diseases. Relief Therapeutics Holding AG is based in Geneva, Switzerland. Show More...
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 2.89 CHF
-
Last Updated 12-12-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CHF -0.29 -0.86 -0.02 -0.07 -0.03 -0.010 -0.010 Dividends CHF Payout Ratio % * Shares Mil 67.0 68.0 543.0 171.0 475.0 652.0 1.266 1.988 2.05 2.104 2.104 Book Value Per Share * CHF 0.09 -0.02 -0.010 0.03 0.03 0.010 0.010 0.010 0.010 0.010 Free Cash Flow Per Share * CHF -0.02 -0.02 -0.12 -0.05 -0.05 -0.010 -0.010 Return on Assets % -31.41 -192.16 -284.14 -51.5 -28.04 -25.52 -54.69 -9.25 -1.31 -26.91 -26.91 Financial Leverage (Average) 1.11 7.06 2.28 1.58 1.71 1.41 1.48 1.67 1.39 1.39 Return on Equity % -35.56 -223.94 -139.36 -52.8 -41.59 -84.4 -13.37 -2.07 -41.93 -41.93 Return on Invested Capital % -35.05 -219.5 -87.02 -41.97 -34.41 -84.39 -12.48 -1.23 -35.83 -35.83 Interest Coverage -47.37 -178.02 -35.08 -20.6 -1.97 -89.76 -89.76 Current Ratio 1.77 0.95 0.19 0.61 0.87 0.82 0.37 0.08 0.18 0.09 0.09 Quick Ratio 0.58 0.87 0.18 0.26 0.73 0.04 0.24 0.07 0.14 0.05 0.05 Debt/Equity 0.010 0.27 0.16 0.010 0.12 0.2